COVID- 19 Reliable - FDA EUA or FDA Cleared Testing and Vaccination
Ages 12 +
* Please bring Health Insurance Card
Rapid Antibody Testing: $75
When we are infected with a virus our body mounts a specific immune response that comes in two phases, the innate and the adaptive. The adaptive response depends on the development of antibodies to help kill the very specific infection. This antibody response starts with a more generalized antibody called IgM while working over the course of a week to a more specific longer lasting antibody called IgG. Determining the presence of specific antibodies, we can judge the time course of infection and wether you are still in an acute phase. Both tests offer near 100% sensitivity and specificity.
Rapid Antigen Testing- Nasal Swab: $150
Using only DA EUA approved Rapid Antigen Tests - these device delivers results from a nasal swab within 15 minutes. It has an exceptional positive predictive value of nearly 100% - If you test positive you are positive... and a negative predictive value (with current level of prevalence) of > 90%.
Monoclonal Antibody IV Therapeutic
Monoclonal Antibodies are laboratory-made protein that mimic the immune’s system’s ability to fight off harmful pathogens such as viruses. You naturally make antibodies to fight infections, but your body may not have antibodies designed to recognize a novel (or new) virus like SARS-CoV-2, the virus that causes COVID-19. Unlike the COVID-19 vaccine, which can take two doses and weeks to help your body develop enough antibodies to prevent an infection, monoclonal antibody treatments quickly give your body the antibodies it needs to protect against an active infection.
Body Lounge is currently administering the REGEN-COV IV infusion made up of the drugs casirivimab and imdevimab administered together. The infusion appointment usually takes about 2 hours for treatment and observation.
In order for this treatment to be impactful, it must be given within 10 days of developing COVID-19 symptoms. Monoclonal antibody infusions were granted emergency use authorization by the FDA and are recommended for adults and pediatric patients (12 or older) who meet one of the following criteria:
- 65 years old or older
- Have a BMI of more than 25 kg/m2, or if age 12-17, have BMI above the 85th percentile for their age and gender based on CDC growth charts
- Currently Pregnant
- Positive COVID test within previous 7 days
- Have a medical condition, including:
- Chronic kidney disease
- Cardiovascular disease (including congenital heart disease, hypertension)
- Down syndrome
- Liver disease
- Chronic lung disease
- Sickle cell disease
- Immunosuppressive disease or immunosuppressive treatment
- Current or former smoker
- History of stroke or cerebrovascular disease
- Current or history of substance abuse
- Neurodevelopmental disorders or other conditions that confer medical complexity
- Have a medical-related technological dependence (e.g., tracheostomy, gastrostomy)